Cargando…

NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications

Key features of chronic lymphocytic leukemia (CLL) are defects in the immune system and the ability of leukemic cells to evade immune defenses and induce immunosuppression, resulting in increased susceptibility to infections and disease progression. Several immune effectors are impaired in CLL, incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sportoletti, Paolo, De Falco, Filomena, Del Papa, Beatrice, Baldoni, Stefano, Guarente, Valerio, Marra, Andrea, Dorillo, Erica, Rompietti, Chiara, Adamo, Francesco Maria, Ruggeri, Loredana, Di Ianni, Mauro, Rosati, Emanuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268440/ https://www.ncbi.nlm.nih.gov/pubmed/34206399 http://dx.doi.org/10.3390/ijms22136665

Ejemplares similares

NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
por: Rosati, Emanuela, et al.
Publicado: (2018)

Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia
por: Guarente, Valerio, et al.
Publicado: (2021)

Bepridil exhibits anti‐leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia
por: Baldoni, Stefano, et al.
Publicado: (2018)

Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia
por: Adamo, Francesco Maria, et al.
Publicado: (2023)

NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells
por: Di Ianni, Mauro, et al.
Publicado: (2018)

NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status
por: Baldoni, Stefano, et al.
Publicado: (2021)

GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL
por: De Falco, Filomena, et al.
Publicado: (2022)

NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential
por: Silva Barcelos, Estevão Carlos, et al.
Publicado: (2023)

IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation
por: De Falco, Filomena, et al.
Publicado: (2018)

Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL
por: De Falco, Filomena, et al.
Publicado: (2015)

Immune correlates of protection by vaccine against SARS‐CoV‐2 in patients with chronic lymphocytic leukaemia
por: Sorcini, Daniele, et al.
Publicado: (2022)

A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect
por: Guardalupi, Francesco, et al.
Publicado: (2023)

FLT3‐targeted therapy restores GATA1 pathway function in NPM1/FLT3‐ITD mutated acute myeloid leukaemia
por: Sorcini, D, et al.
Publicado: (2023)

GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations
por: Sportoletti, Paolo, et al.
Publicado: (2019)

Lessons, Challenges and Future Therapeutic Opportunities for PI3K Inhibition in CLL
por: Guarente, Valerio, et al.
Publicado: (2021)

NOTCH and Graft-Versus-Host Disease
por: Di Ianni, Mauro, et al.
Publicado: (2018)

Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice
por: Sportoletti, Paolo, et al.
Publicado: (2020)

Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia
por: Hofland, Tom, et al.
Publicado: (2019)

Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib
por: Mauro, Francesca Romana, et al.
Publicado: (2021)

Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia
por: Wang, Zong-Han, et al.
Publicado: (2023)

A case report of extranodal NK/T-cell lymphoma in patient with chronic lymphocytic leukemia
por: Ge, Hangping, et al.
Publicado: (2018)

How does the NPM1 mutant induce leukemia?
por: Sportoletti, Paolo
Publicado: (2011)

BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia
por: Sordo-Bahamonde, Christian, et al.
Publicado: (2021)

Aggressive NK-Cell Leukemia
por: Ishida, Fumihiro
Publicado: (2018)

Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia
por: Limongello, Roberto, et al.
Publicado: (2021)

Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
por: Moretta, Lorenzo, et al.
Publicado: (2014)

Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin
por: La Starza, Roberta, et al.
Publicado: (2018)

Expansion of NK Cells and Reduction of NKG2D Expression in Chronic Lymphocytic Leukemia. Correlation with Progressive Disease
por: Huergo-Zapico, Leticia, et al.
Publicado: (2014)

Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells
por: Sánchez-Martínez, Diego, et al.
Publicado: (2016)

Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy
por: Yano, Max, et al.
Publicado: (2022)

The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma
por: Pessina, Sara, et al.
Publicado: (2015)

Novel Approaches to Treatment of Acute Myeloid Leukemia Relapse Post Allogeneic Stem Cell Transplantation
por: Liberatore, Carmine, et al.
Publicado: (2023)

Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire
por: Meazza, Raffaella, et al.
Publicado: (2023)

COVID-19 Pandemic Impact on Chronic Lymphocytic Leukemia (CLL) Patients' Preferences Towards Therapies: The Italian Experience (CHOICE Study)
por: Molica, Stefano, et al.
Publicado: (2021)

Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage
por: Arriga, Roberto, et al.
Publicado: (2015)

Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells
por: Acebes-Huerta, Andrea, et al.
Publicado: (2014)

Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia
por: Villa-Álvarez, Mónica, et al.
Publicado: (2018)

Molecular Features and Diagnostic Challenges in Alpha/Beta T-Cell Large Granular Lymphocyte Leukemia
por: Gaudio, Francesco, et al.
Publicado: (2022)

Calreticulin arms NK cells against leukemia
por: Fucikova, Jitka, et al.
Publicado: (2019)

Daratumumab‐based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia
por: Liberatore, Carmine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8e7ehf8kgtc9cbghtskvhnkisb